Quarterly report pursuant to Section 13 or 15(d)

Discontinued Operations - Reconciliation of Loss from Discontinued Operations (Details)

v3.24.3
Discontinued Operations - Reconciliation of Loss from Discontinued Operations (Details) - USD ($)
$ in Thousands
3 Months Ended 12 Months Ended
Sep. 30, 2024
Sep. 30, 2023
Jun. 30, 2024
Results of operations for discontinued operations      
Research and development $ 1,305 $ 1,606  
Loss from discontinued operations   (672)  
iBio CDMO, LLC | Discontinued Operations      
Results of operations for discontinued operations      
General and administrative   364  
Fixed asset impairments     $ 3,100
Loss (gain) on sale of fixed assets   (50) 4,800
Total operating expenses   314  
Interest expense - term note payable   (358)  
Gain on extinguishment of debt     $ 800
Total other expenses   (358)  
Loss from discontinued operations   $ (672)